
浏览全部资源
扫码关注微信
纸质出版:2011
移动端阅览
张剑,张琪,姜楠,张英才,汪国营,李华,汪根树,杨扬,陈规划.CTLA4Ig和CD40LIg基因修饰骨髓间充质干细胞在异种胰岛移植排斥反应中的作用[J].陆军军医大学学报(原第三军医大学学报),2011,33(23):2450-2453.
Zhang Jian,Zhang Qi,Jiang Nan,Zhang Yingcai,Wang Guoying,Li Hua,Wang Genshu,Yang Yang,Chen Guihua.Effects of CTLA4Ig and CD40LIg modified bone marrow mesenchymal stem cells on rejection of rat islet xenografts[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(23):2450-2453.
张剑,张琪,姜楠,张英才,汪国营,李华,汪根树,杨扬,陈规划.CTLA4Ig和CD40LIg基因修饰骨髓间充质干细胞在异种胰岛移植排斥反应中的作用[J].陆军军医大学学报(原第三军医大学学报),2011,33(23):2450-2453. DOI:
Zhang Jian,Zhang Qi,Jiang Nan,Zhang Yingcai,Wang Guoying,Li Hua,Wang Genshu,Yang Yang,Chen Guihua.Effects of CTLA4Ig and CD40LIg modified bone marrow mesenchymal stem cells on rejection of rat islet xenografts[J].J Amry Med Univ (J Third Mil Med Univ),2011,33(23):2450-2453. DOI:
目的 探讨细胞毒性T淋巴细胞相关抗原4免疫球蛋白(CTLA4Ig)和T细胞分化群40补体免疫球蛋白(CD40LIg)基因修饰骨髓间充质干细胞(MSCs)在异种胰岛移植排斥反应中的作用及其可能的机制。 方法 将SD大鼠胰岛细胞移植到Wistar糖尿病大鼠肾包膜下,建立SD-Wistar大鼠的异种胰岛移植模型,用携带CTLA4Ig和CD40LIg基因重组腺病毒感染的MSCs进行干预治疗。取造模成功的糖尿病大鼠45只,按随机数字表法分为3组(每组15只):对照组只植入胰岛细胞;单纯MSCs组植入胰岛细胞和MSCs;基因转染MSCs组植入胰岛细胞及CTLA4Ig和CD40LIg基因转染的MSCs。观察胰岛移植后糖尿病大鼠的生存情况、血糖变化和移植物病理形态学的改变,检测移植物CTLA4Ig、CD40LIg和胰岛素的表达以及胰岛移植大鼠细胞因子水平的变化。 结果 ①糖尿病大鼠血糖在移植后2 d降至正常,对照组血糖平均在移植后8 d升高,单纯MSCs组和基因转染MSCs组血糖分别在21 d和49 d升高。②对照组、单纯MSCs组和基因转染MSCs组,移植物存活时间分别为(10.2±2.1)、(23.5±6.8)和(52.1±7.3)d,各组间比较差异有统计学意义(P0.05);移植大鼠的生存时间分别为(21.3±5.3)、(49.7±8.5)、(95.8±13.8)d,各组间比较和移植物存活时间相似(P0.05)。③对照组TNF-α和IL-2的水平在移植后1周内均急剧上升,而IL-4和IL-10的水平较移植前显著下降(P0.01);2个治疗组细胞因子水平的变化和对照组正好相反。④ 2个治疗组移植物内可见成片的胰岛细胞团,未见明显淋巴细胞浸润,基因转染MSCs组移植物内可见CTLA4Ig、CD40LIg和胰岛素的表达。 结论 转移CTLA4Ig和CD40LIg基因修饰MSCs可抑制异种胰岛移植排斥反应,其效果优于MSCs单独应用。
Objective To investigate the effects of cytotoxic T lymphocyte associated antigen 4 immuno-globulin (CTLA4Ig) and cluster of differentiation 40 ligand immunoglobulin (CD40LIg) modified bone marrow mesenchymal stem cells (MSCs) on rejection of rat islet xenografts. Methods The islet xenografts model of SD-Wistar rat was established with islet cells of SD rats transplant under left kidney capsule of diabetic Wistar rats. MSCs infected with recombinant adenoviruses containing CTLA4Ig and CD40LIg gene were applied in treatment. Forty-five successfully modeling diabetic rats were randomly divided into three groups with 15 rats in each group: only islet cells were transplanted to rats in control group (A); islet cells and MSCs were transplanted to rats in MSCs group (B); and islet cells and MSCs transfected with CTLA4Ig and CD40LIg gene were transplanted to rats in transfected MSCs group (C). Survival of rats
blood glucose and morphological changes of grafts were observed after islet transplantation. Expressions of CTLA4Ig
CD40LIg and insulin were detected by immunohistochemical staining and cytokines changes were quantified by ELISA. Results ①The blood glucose of transplant rats decreased to normal level on day 2 post-transplantation. The average level of blood glucose of group A
group B and group C increased on day 8
21 and 49 post-transplantation
respectively. ②The grafts of the group A
B and C survived for (10.2±2.1)
(23.5±6.8) and (52.1±7.3) days
respectively. There were significant differences among group A
B and C (P0.05). The survival time of transplant rats were (21.3±5.3)
(49.7±8.5) and (95.8±13.8) days in group A
B and C
respectively. The survival time of transplant rats among each group was the same as that of grafts (P0.05). ③In group A
serum levels of IL-2 and TNF-α increased dramatically and serum levels of IL-4 and IL-10 decreased significantly within 7 days post-transplantation compared with those before transplantation (P0.01). Serum levels of IL-4 and IL-10 in group B and C increased significantly post-transplantation compared with those before transplantation. ④Hematoxylin-eosin staining of grafts showed in group B and C
bolus of islets under kidney capsule with no lymphocytes infiltration and immunohistochemical staining of grafts showed expression of insulin protein at islets in group B and C. These grafts positively stained for CTLA4Ig and CD40LIg in group C. Conclusion CTLA4Ig and CD40LIg modified MSCs can inhibit the rejection of rat islet xenografts
and the effect are superior to MSCs alone.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621